2011 annual financial data
ResMed 2011 Operating cash flow growth
Direct answer
Operating cash flow growth was 50.46%.
Operating income was 266,924,000 USD and net income was 226,986,000 USD.
Operating cash flow was 283,190,000 USD.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,243,148,000 USD
- Operating income
- 266,924,000 USD
- Net income
- 226,986,000 USD
- Operating cash flow
- 283,190,000 USD